INVESTIGATING ASCL1-DRIVEN IMMUNOLOGICAL LANDSCAPES IN NEUROENDOCRINE PROSTATE CANCER: A STRATEGY FOR ENHANCING IMMUNOTHERAPY EFFICACY
$426,154FY2025Defense Health AgencyDOD
The University Of British Columbia
Investigators
View source on USAspending →INVESTIGATING ASCL1-DRIVEN IMMUNOLOGICAL LANDSCAPES IN NEUROENDOCRINE PROSTATE CANCER: A STRATEGY FOR ENHANCING IMMUNOTHERAPY EFFICACY · GrantIndex